SCHEMBL30358447

SCHEMBL30358447

CNC(=O)c1cccc(C(=O)N[C@H](C)c2ccccc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.71
LMNA P02545 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
NPC1 O15118 1/20 0.59
GPR139 Q6DWJ6 5/20 0.56
MAPK1 P28482 2/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
GAA P10253 1/20 0.56
PKM P14618 1/20 0.56
ROCK2 O75116 1/20 0.54
RPS6KA5 O75582 1/20 0.54
MAP4K4 O95819 1/20 0.54
CDK1 P06493 1/20 0.54
CSF1R P07333 1/20 0.54
PRKACA P17612 1/20 0.54
FLT1 P17948 1/20 0.54
RPS6KB1 P23443 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13229107 0.89 ALDH1A1 (0.73) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL3345042 0.86 ALDH1A1 (0.69) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL3646228 0.86 ALDH1A1 (0.69) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL3508505 0.86 ALDH1A1 (0.69) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL3351175 0.86 ALDH1A1 (0.69) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL13229106 0.85 ALDH1A1 (0.68) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL5968858 0.85 ALDH1A1 (0.77) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL1101522 0.85 ALDH1A1 (0.77) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL751213 0.85 ALDH1A1 (0.77) ALDH1A1LMNASMN1; SMN2NPC1GPR139
SCHEMBL8547159 0.83 ALDH1A1 (1.00) ALDH1A1LMNASMN1; SMN2NPC1GPR139

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023004291-A1 CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME BAYLOR COLLEGE OF MEDICINE (US) 2023-01-26 WO disclosed